Company News
Orchid Pharma Signs $178M Russia Exblifep Agreement
Orchid Pharma entered exclusive licensing and supply agreement with Pharmasyntez JSC for Exblifep antibiotic in Russian market.
Partnership represents potential $178 million opportunity over first 10
